Skip to content

Clinical trials

Phase 3 Polyneuropathies trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polyneuropathies Phase: Phase 3 Country / region: France Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20151
20161
20191
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals1
Assistance Publique - Hôpitaux de Paris1
Baxalta now part of Shire1
Eidos Therapeutics, a BridgeBio company1
Institut Mutualiste Montsouris1
Ionis Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polyneuropathies6
Amyloidosis3
Alzheimer Disease1
Amyloid Neuropathies, Familial1
Autoimmune Diseases1
Autoimmune Diseases of the Nervous System1
Cardiomyopathies1
Demyelinating Diseases1
Heart Diseases1
Immune System Diseases1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.